Skip to content

Author

M. Corasaniti

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

791. From Preclinical Evidence to Clinical Innovation: NanoBEO as first-in-class novel therapeutic for Neuropsychiatric symptoms and Pain in Severe Dementia

Abstract Background Dementia currently affects some 57.4 million people worldwide and approximately 99% of patients with Alzheimer’s Disease (AD) exhibit neuropsychiatric symptoms (NPS). Agitation is a particularly resistant clinical burden characterized by verbal and physical aggression that compromises safety. Author...

D. Scuteri, M. Contrada, K. Hamamura et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.